Power, sample size and adaptation considerations in the design of group sequential clinical trials
From MaRDI portal
Publication:3429959
DOI10.1093/BIOMET/91.3.507zbMath1113.62090OpenAlexW2315952772MaRDI QIDQ3429959
Tze Leung Lai, Mei-Chiung Shih
Publication date: 20 March 2007
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/91.3.507
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Optimal stopping in statistics (62L15)
Related Items (11)
Most powerful test sequences with early stopping options ⋮ Bandit Theory: Applications to Learning Healthcare Systems and Clinical Trials ⋮ Generalized Sequential Probability Ratio Test for Separate Families of Hypotheses ⋮ Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials ⋮ Modern sequential analysis and its applications to computerized adaptive testing ⋮ Asymptotically optimal multistage tests of simple hypotheses ⋮ Efficient Adaptive Randomization and Stopping Rules in Multi-arm Clinical Trials for Testing a New Treatment ⋮ Active Postmarketing Drug Surveillance for Multiple Adverse Events ⋮ Complementary hypotheses in safety surveillance ⋮ Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes ⋮ Asymptotically Optimal Sequential Design for Rank Aggregation
This page was built for publication: Power, sample size and adaptation considerations in the design of group sequential clinical trials
